Isolation of mtDNA knock-out mice by introduction of disease-related mtDNA mutation
通过引入疾病相关 mtDNA 突变来分离 mtDNA 敲除小鼠
基本信息
- 批准号:06557040
- 负责人:
- 金额:$ 10.11万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (A)
- 财政年份:1994
- 资助国家:日本
- 起止时间:1994 至 1996
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
For isolation of the mouse mtDNA-less (rho^0) cell lines, we searched for various anti-mitochondrial drugs which were expected to decrease the mtDNA content, and found that treatment with ditercalinium, an antitumor bis-intercalating agent, was extremely effective for completely excluding mtDNA in all the mouse cell lines we tested. The resulting rho^0 mouse cells were successfully used for trapping mtDNA of living nerve cells into dividing cultured cells by fusion of the rho^0 cells with mouse brain synaptosomes, which represent synaptic endings isolated from nerve cells. The cybrid clones with neuronal mtDNA obtained all restored mitochondrial translation activity similarly irrespective of whether the mtDNA was derived from young or aged mice, suggesting that at least defects in mitochondrial genomes are not involved in the age-associated mitochondrial dysfunction observed in the brain of aged mice. Furthermore, we could trap a very small amount of a common 5823 bp-deletion mutant mtDNA (DELTAmtDNA^<5823>) that was detectable by PCR in the cybrid clones. As the amount of mutant mtDNA with large-scale deletions was expected to increase during prolonged cultivation of the cybrids, these cells should be available for establishment of mice containing the deletion mutant mtDNA.
为了分离小鼠无线粒体DNA(rho^0)细胞系,我们寻找了各种预期会降低线粒体DNA含量的抗线粒体药物,并发现用抗肿瘤双嵌入剂ditercalinium处理对完全排除我们测试的所有小鼠细胞系中的线粒体DNA非常有效。通过将rho^0细胞与小鼠脑突触体(代表从神经细胞中分离的突触末梢)融合,所得到的rho^0小鼠细胞成功地用于将活神经细胞的mtDNA捕获到分裂的培养细胞中。具有神经元mtDNA的胞质杂交体克隆获得了所有恢复的线粒体翻译活性,无论mtDNA是来自年轻小鼠还是老年小鼠,这表明至少线粒体基因组中的缺陷不涉及在老年小鼠脑中观察到的与年龄相关的线粒体功能障碍。此外,我们可以捕获非常少量的常见的5823 bp缺失突变体mtDNA(DELTAmtDNA^<5823>),其可以通过PCR在胞质杂交体克隆中检测到。由于在胞质杂交体的长期培养期间,具有大规模缺失的突变mtDNA的量预计会增加,因此这些细胞应该可用于建立含有缺失突变mtDNA的小鼠。
项目成果
期刊论文数量(48)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
林純一: "ミトコンドリア病:ミトコンドリアの体細胞遺伝学" 最新医学. (印刷中). (1995)
Junichi Hayashi:“线粒体疾病:线粒体的体细胞遗传学”现代医学(出版中)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Sadamitsu Asoh: "Expression of the apoptosis-mediator Fas is enhanced by dysfunctional mitochondria" J.Biochem.120. 600-607 (1996)
Sadamitsu Asoh:“线粒体功能障碍增强了凋亡介导 Fas 的表达”J.Biochem.120。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Hideki Kaneda: "Selective elimination of paternal mitochondrial DNA during mouse embryogenesis." Proc.Natl.Acad.Sci.USA. 92. 4542-4546 (1995)
Hideki Kaneda:“在小鼠胚胎发生过程中选择性消除父本线粒体 DNA。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
林 純一: "ヒトのミトコンドリアとミトコンドリアゲノムは機械的に連続した一つの単位として働く" 蛋白質 核酸 酵素. 40. 143-150 (1995)
Junichi Hayashi:“人类线粒体和线粒体基因组作为一个机械连续单位发挥作用”蛋白质核酸酶。 40. 143-150 (1995)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kimiko Inoue: "Mutant mtDNA at 1555 A to G in 12S rRNA gene and hypersusceptibility of mitochondrial translation to streptomycin can be co-transferred to ρ^o HeLa cells" Biochem.Biophys.Res.Commun.223. 496-501 (1996)
Kimiko Inoue:“12S rRNA 基因中 1555 A 至 G 处的突变 mtDNA 和线粒体翻译对链霉素的超敏感性可以共同转移至 ρ^o HeLa 细胞”Biochem.Biophys.Res.Commun.223 (1996)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HAYASHI Jun-ichi其他文献
HAYASHI Jun-ichi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HAYASHI Jun-ichi', 18)}}的其他基金
Analysis of entire physiological roles of mammalian mtDNA by generation of mice carrying various pathogenic mutations
通过产生携带各种致病突变的小鼠来分析哺乳动物线粒体DNA的整个生理作用
- 批准号:
19100007 - 财政年份:2007
- 资助金额:
$ 10.11万 - 项目类别:
Grant-in-Aid for Scientific Research (S)
Studies on pathogenesis and gene therapy using mice with the mutated mtDNA in tRNA genes
tRNA基因mtDNA突变小鼠的发病机制和基因治疗研究
- 批准号:
14035101 - 财政年份:2002
- 资助金额:
$ 10.11万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
Generation and application of mtDNA knockout mice as models for mitochondrial diseases
线粒体DNA敲除小鼠线粒体疾病模型的产生及应用
- 批准号:
10358018 - 财政年份:1998
- 资助金额:
$ 10.11万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Generation and application of mtDNA knockout mice models of aging
线粒体DNA敲除小鼠衰老模型的构建及应用
- 批准号:
10832001 - 财政年份:1998
- 资助金额:
$ 10.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analyzes of genes responsible for aging and the pathogenesis of diabetes by isolation of transgenic mice with pathogenic mtDNA mutation
通过分离具有致病性 mtDNA 突变的转基因小鼠来分析导致衰老和糖尿病发病机制的基因
- 批准号:
07458226 - 财政年份:1995
- 资助金额:
$ 10.11万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似海外基金
Utilization of an energy metabolic control compound to treat mitochondrial diseases
利用能量代谢控制化合物治疗线粒体疾病
- 批准号:
22KF0400 - 财政年份:2023
- 资助金额:
$ 10.11万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Drosophila models of human mitochondrial diseases
人类线粒体疾病的果蝇模型
- 批准号:
10756280 - 财政年份:2023
- 资助金额:
$ 10.11万 - 项目类别:
Mitochondrial genomics in human health and diseases.(How variation in nuclear and mitochondrial DNA causes rare mitochondrial diseases and common late-onset human disorders)
人类健康和疾病中的线粒体基因组学。(核和线粒体 DNA 的变异如何导致罕见的线粒体疾病和常见的迟发性人类疾病)
- 批准号:
MC_UU_00028/7 - 财政年份:2022
- 资助金额:
$ 10.11万 - 项目类别:
Intramural
First murine animal model and adeno-associated virus (AAV)-based gene therapy for MTATP6 mitochondrial diseases
首个针对 MTATP6 线粒体疾病的小鼠动物模型和基于腺相关病毒 (AAV) 的基因治疗
- 批准号:
10684251 - 财政年份:2022
- 资助金额:
$ 10.11万 - 项目类别:
First murine animal model and adeno-associated virus (AAV)-based gene therapy for MTATP6 mitochondrial diseases
首个针对 MTATP6 线粒体疾病的小鼠动物模型和基于腺相关病毒 (AAV) 的基因治疗
- 批准号:
10506768 - 财政年份:2022
- 资助金额:
$ 10.11万 - 项目类别:
Development of the therapy for mitochondrial diseases
线粒体疾病疗法的开发
- 批准号:
22K15905 - 财政年份:2022
- 资助金额:
$ 10.11万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
New Transformation Technology for Gene Editing of Human Mitochondrial DNA Associated With Mitochondrial Diseases
与线粒体疾病相关的人类线粒体 DNA 基因编辑的新转化技术
- 批准号:
10382077 - 财政年份:2022
- 资助金额:
$ 10.11万 - 项目类别:
Targeting the cellular metabolism to treat tissue-specific mitochondrial diseases
靶向细胞代谢来治疗组织特异性线粒体疾病
- 批准号:
MR/V009346/1 - 财政年份:2021
- 资助金额:
$ 10.11万 - 项目类别:
Research Grant
Emerging therapeutic candidates for rare maternally inherited mitochondrial diseases with shared etiologies
具有共同病因的罕见母系遗传线粒体疾病的新兴治疗候选药物
- 批准号:
10702207 - 财政年份:2021
- 资助金额:
$ 10.11万 - 项目类别:
Emerging therapeutic candidates for rare maternally inherited mitochondrial diseases with shared etiologies
具有共同病因的罕见母系遗传线粒体疾病的新兴治疗候选药物
- 批准号:
10439890 - 财政年份:2021
- 资助金额:
$ 10.11万 - 项目类别: